OncoArendi Therapeutics SA (1B1) Financial Statements
OncoArendi Therapeutics SA Financial Overview
OncoArendi Therapeutics SA's market cap is currently $32.31M. The company's EPS TTM is $-0.50; its P/E ratio is -9.04; OncoArendi Therapeutics SA has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 2.92M | $ 100.00 | $ 7.51M | $ 400.00 |
| Gross Profit | $ 0.00 | $ -489.91K | $ -4.10M | $ -21.33K | $ -2.77M |
| Operating Income | $ -22.04M | $ -33.61M | $ -32.13M | $ -43.91M | $ -13.76M |
| EBITDA | $ -19.03M | $ -27.37M | $ -25.51M | $ -31.85M | $ -13.33M |
| Net Income | $ -15.69M | $ -31.29M | $ -28.37M | $ -13.54M | $ -13.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 16.35M | $ 18.19M | $ 63.99M | $ 65.62M | $ 102.04M |
| Total Assets | $ 94.43M | $ 113.72M | $ 112.27M | $ 138.06M | $ 151.59M |
| Total Debt | $ 5.29M | $ 7.23M | $ 7.14M | $ 6.41M | $ 6.01M |
| Net Debt | $ -11.06M | $ -10.96M | $ -56.85M | $ -59.21M | $ -96.03M |
| Total Liabilities | $ 6.99M | $ 10.31M | $ 11.34M | $ 11.61M | $ 10.45M |
| Stockholders' Equity | $ 87.45M | $ 103.41M | $ 100.93M | $ 126.45M | $ 141.14M |
| Cash Flow | |||||
| Free Cash Flow | $ -19.41M | $ -80.76M | $ -23.65M | $ -43.84M | $ -32.33M |
| Operating Cash Flow | $ -19.41M | $ -56.99M | $ -23.29M | $ -10.21M | $ -13.50M |
| Investing Cash Flow | $ -16.60M | $ -23.57M | $ -33.87M | $ -33.59M | $ -18.82M |
| Financing Cash Flow | $ 34.46M | $ 34.76M | $ 55.53M | $ 7.38M | $ 13.86M |
Currency in PLN